Sonja Bernhard

Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial

Victor Kande Betu Ku Mesu, Wilfried Mutombo Kalonji, Clélia Bardonneau et al. · The Lancet · 2017 · 269 citations

Veterinary Medicine, Biology, Infectious Diseases +15

Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study

Victor Kande Betu Ku Mesu, Wilfried Mutombo Kalonji, Clélia Bardonneau et al. · The Lancet Global Health · 2021 · 56 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +16

Efficacy and Safety of Pafuramidine versus Pentamidine Maleate for Treatment of First Stage Sleeping Sickness in a Randomized, Comparator-Controlled, International Phase 3 Clinical Trial

Gabriele Pohlig, Sonja Bernhard, Johannes Blum et al. · PLoS neglected tropical diseases · 2016 · 41 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +16

Melarsoprol- and pentamidine-resistant Trypanosoma brucei rhodesiense populations and their cross-resistance

Sonja Bernhard, Barbara Nerima, Pascal Mäser et al. · International Journal for Parasitology · 2007 · 36 citations

Life Sciences, Infectious Diseases, Microbiology +12

Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study

Andrea Kuemmerle, Caecilia Schmid, Sonja Bernhard et al. · PLoS neglected tropical diseases · 2021 · 31 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +14